Medical history (history of illness) represents an important component in the diagnosis of dysgeusia (taste disorder).
Family history
Social history
Current anamnesis/systemic anamnesis (somatic and psychological complaints).
- How long have the taste disorders been present?
- What changes exactly have you noticed? Do you taste less, not at all or do you suffer from qualitative taste disorders?
- Have you noticed any other changes?
- Do you suffer from dry mucous membranes?
Vegetative anamnesis incl. nutritional anamnesis.
- Has your appetite changed?
Self history including medication history.
- Pre-existing conditions (metabolic diseases, neurological diseases, injuries).
- Operations
- Radiotherapy
- Allergies
Medication history
- ACE inhibitor (captopril)
- Angiotensin II receptor blockers (synonyms: AT-II-RB; ARB; angiotensin II receptor subtype 1 antagonists; AT1 receptor antagonists, AT1 antagonists; angiotensin receptor blockers, “sartans“) – eg, losartan.
- Antibiotics
- Doxycycline
- Gyrase inhibitors (quinolones (with the fluoroquinolone subgroup), cinnolines (cinnolin), naphthyridines (nalidixic acid), pyridopyrimidines).
- Macrolides (azithromycin, clarithromycin, erythromycin, josamycin, roxithromycin, spiramycin, tylosin).
- Nitroimidazoles (metronidazole).
- Antidepressants (amitriptyline)
- Antidiabetic drugs – e.g., glibicides.
- Antiepileptic drugs (synonym: anticonvulsants) – carbamazepine, phenytoin, lamotrigine.
- Antifungal drugs – e.g., terbinafine
- Antiseptics, local (chlorhexidine).
- Calcium antagonists (diltiazem, nifedipine
- Diuretics
- Potassium-sparing diuretics – aldosterone antagonist (spironolactone).
- Thiazide diuretics (hydrochlorothiazide, HCT).
- Migraine drugs – triptans
- Muscle relaxants – e.g. baclofen
- Penicillamine – drug in the therapy of chronic polyarthritis.
- Parkinson’s drugs – e.g. levodopa
- Sibutramine
- Tranquilizers (individual substances of the benzodiazepine group).
- Uricostatic drugs (allopurinol)
- Cytostatic drugs – e.g., cisplatin, methotrexate (MTX).
